Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD.
Hong X, Xiao Y, Xu L, Shen L, Neelagar R, Devakumar V, Trinh-Minh T, Liang M, Rius Rigau A, Zhang Y, Li YN, Dees C, Györfi AH, Wolff D, Herr W, Schett G, Distler JHW, Matei AE.
Hong X, et al. Among authors: herr w.
Blood Adv. 2025 Mar 25;9(6):1261-1266. doi: 10.1182/bloodadvances.2024014387.
Blood Adv. 2025.
PMID: 39775728
Free PMC article.
No abstract available.